Bio-Rad Laboratories, Inc. Profile Avatar - Palmy Investing

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. Th…
Medical - Devices
US, Hercules [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
56.04 56.64 56.81 56.11 55.26 54.18 55.54 55.03 54.97 53.46 54.38 56.48 56.14 55.93 53.58
Profit Margin
8.11 9.63 8.60 8.18 3.65 4.08 5.60 1.36 5.31 15.76 76.08 149.83 145.57 -129.45 -23.86
Operating Margin
12.95 14.74 14.23 12.76 7.95 6.90 8.26 2.57 5.40 -4.74 9.93 16.14 16.75 17.22 14.37
EPS Growth
60.00 26.89 -4.63 -8.45 -53.50 13.24 21.43 -76.47 368.18 193.69 387.03 116.97 11.54 -185.40 82.08
Return on Assets (ROA)
5.70 6.06 5.76 4.93 2.30 2.66 3.05 0.73 2.69 6.44 21.96 29.40 23.93 -26.87 -5.18
Return on Equity (ROE)
11.48 12.07 10.22 8.39 3.56 4.07 4.54 1.09 3.92 8.99 30.56 38.61 31.13 -37.73 -7.29
Return on Invested Capital (ROIC)
9.26 9.64 9.00 7.02 4.47 3.86 4.42 1.19 4.07 -1.74 2.88 3.22 2.79 3.44 2.89
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
29.30 31.48 23.65 21.39 12.91 13.05 11.75 11.29 10.18 7.84 5.49 0.11 0.06 8.87 10.01
Debt/Equity
58.99 62.75 42.00 36.41 20.00 19.95 17.51 16.80 14.85 10.94 7.64 0.14 0.08 12.46 14.08
Debt/EBITDA
27.67 14.69 38.04 65.04 32.14 7.26 -6.96 -7.96 17.71 2.16 -56.65 -113.00 -70.74 114.97 173.89
Debt/Capitalization
37.10 38.56 29.58 26.69 16.67 16.63 14.90 14.38 12.93 9.86 7.10 0.14 0.08 11.08 12.34
Interest Debt per Share USD
28.83 37.16 28.03 27.69 17.44 15.86 15.68 15.50 15.41 15.53 15.52 1.21 0.42 41.51 43.83
Debt Growth
63.11 29.77 -24.04 0.23 -40.42 -0.33 0.01 -0.34 0.11 1.02 0.07 -96.80 -21.72 10,789.59 17.34
Liquidity
Current Ratio
372.09 296.32 391.66 417.31 358.56 384.18 402.76 391.35 393.31 450.55 240.77 338.83 292.11 555.29 583.08
Quick Ratio
259.67 211.99 263.94 286.14 211.62 240.68 267.81 258.07 243.76 276.76 167.08 224.23 190.77 402.82 404.32
Cash Ratio
154.76 135.99 125.07 100.47 68.01 92.50 103.67 96.81 76.35 96.04 72.96 104.86 69.14 76.35 77.27
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
223.35 209.91 206.60 202.55 190.35 211.58 183.14 177.17 163.54 182.39 190.37 178.03 224.01 171.68 158.86
Receivables Turnover
516.07 496.69 520.11 518.95 504.59 575.96 515.84 555.44 464.70 582.51 588.70 606.93 690.03 566.52 533.27
Payables Turnover
843.55 736.63 693.63 693.42 642.53 774.86 320.35 313.72 317.05 402.97 367.35 305.75 305.99 374.41 868.14
Asset Turnover
70.36 62.92 66.96 60.30 62.93 65.10 54.41 53.71 50.57 40.87 28.86 19.62 16.44 20.75 21.72
Coverage
Interest Coverage
491.21 445.74 555.48 536.12 276.57 677.71 768.52 242.43 532.31 -453.39 980.79 1,879.86 31,555.77 1,266.24 776.30
Asset Coverage
200 200 300 300 600 600 700 700 800 1,100 1,600 86,300 153,000 1,000 800
Cash Flow Coverage (CFGR)
43.75 23.43 35.47 37.99 40.12 62.69 42.71 49.81 23.88 64.97 104.13 4,093.11 5,966.75 16.23 30.46
EBITDA Coverage
700 600 700 800 500 1,400 1,400 1,200 1,300 1,500 1,600 2,600 41,900 1,700 1,100
Dividend Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
5.47 6.46 6.62 5.70 2.20 2.55 2.80 0.52 1.62 5.21 15.93 21.98 18.88 -28.96 -6.76
Price/Earnings (P/E)
1,827.82 1,548.88 1,510.52 1,756.07 4,542.38 3,918.39 3,578.41 19,080.26 6,168.52 1,919.28 627.90 454.95 529.81 -345.26 -1,479.83
Price/Book (P/B)
209.84 186.96 154.37 147.40 161.59 159.32 162.49 207.45 241.53 172.53 191.88 175.64 164.92 130.25 107.90
Price/Sales (P/S)
148.15 149.08 129.83 143.62 165.68 160.06 200.40 259.47 327.65 302.54 477.70 681.68 771.23 446.94 353.07
Price/Cash Flow (P/CF)
813.17 1,271.76 1,036.16 1,065.57 2,013.67 1,273.74 2,173.32 2,479.44 6,813.07 2,426.85 2,411.64 3,016.19 3,433.16 6,440.98 2,515.39
End of BIO's Analysis
CIK: 12208 CUSIP: 090572207 ISIN: US0905722072 LEI: - UEI: -
Secondary Listings